| Gene symbol | CD276 | Synonyms | 4Ig-B7-H3, B7-H3, B7H3, B7RP-2 | Type of gene | protein-coding |
| Chromosome | 15 | Map location | 15q24.1 | dbXrefs | |
| Description | CD276 molecule | ||||
| GTO ID | GTC2676 |
| Trial ID | NCT04864821 |
| Disease | Osteosarcoma | Lung Cancer | Neuroblastoma | Stomach Cancer |
| Altered gene | CD276 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | B7-H3 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor |
| Year | 2021 |
| Country | China |
| Company sponsor | PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
| Other ID(s) | PA-P276-001 |
| Cohort 1 | |||||||||
|
|||||||||